J. Blaize

Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center

Hiral S. Patel, Shou-Ching Tang, F. Kreidieh, 2022, JCO precision oncology.

Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to date

L. Bryan, J. Blaize, F. Mensah, 2018, OncoTargets and therapy.

The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA).

M. Espinoza-Gutarra, J. Blaize, Snegha Ananth, 2024, Leukemia & lymphoma.